IFNG and neoplasm: Tumors from mice treated with TIN + GSK484 had 1.8-fold higher levels of T cells and a 2.2-fold increase in the production of IFN-γ from T cells in tumors, which was also observed in mice treated with TIN + aPD-L1, indicating an increased anti-tumor response compared with control mice (184).